Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease ...

Sending letters to encourage guideline-directed practice in the management of chronic kidney disease to either patients or their general practitioner does not improve prescription rates, shows trial.

For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone, ...